Cargando…
Metabolic profile and safety of piperlongumine
Piperlongumine (PPL), a natural plant product, has been extensively studied in cancer treatment going up on clinical trials. Since the first report related to its use on cancer research (in 2011) around 80 papers have been published in less than 10 years, but a gap still remaining. There are no meta...
Autores principales: | de Lima Moreira, Fernanda, Habenschus, Maísa D., Barth, Thiago, Marques, Lucas M. M., Pilon, Alan Cesar, da Silva Bolzani, Vanderlan, Vessecchi, Ricardo, Lopes, Norberto P., de Oliveira, Anderson R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041077/ https://www.ncbi.nlm.nih.gov/pubmed/27681015 http://dx.doi.org/10.1038/srep33646 |
Ejemplares similares
-
Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016) -
Details of the cooperative binding of piperlongumine with rat serum albumin obtained by spectroscopic and computational analyses
por: Povinelli, Ana Paula Ribeiro, et al.
Publicado: (2019) -
Biological and physical approaches on the role of piplartine (piperlongumine) in cancer
por: Henrique, Tiago, et al.
Publicado: (2020) -
Unravelling the Interaction of Piperlongumine with the Nucleotide-Binding Domain of HSP70: A Spectroscopic and In Silico Study
por: Povinelli, Ana Paula Ribeiro, et al.
Publicado: (2021) -
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023)